Gain Therapeutics (GANX) Total Debt (2020 - 2026)
Gain Therapeutics' Total Debt came in at $343,686 for Q2 2026, down 23.9% from $451,467 a year earlier and down 8.0% from the prior quarter.
Powered by 
Analysis
Gain Therapeutics (GANX) Total Debt (2020 - 2026) Analysis & Trends
At the end of FY2025, Gain Therapeutics' Total Debt was $400,953, down 8.6% from FY2024.
- Total Debt has declined in each of the last five years, with a five-year compound annual growth rate of -11.5% (FY2020 to FY2025).
- Going back by year, Total Debt was $438,504 in FY2024 (-22.8%), $567,850 in FY2023 (-5.9%), $603,393 in FY2022 (-13.1%) and $694,294 in FY2021 (-6.0%).
- The Q2 2026 figure represents the lowest quarterly Total Debt in data going back to Q4 2020.
- Year-over-year, Total Debt has declined for 19 consecutive quarters, with an average decline of 14.3% over the last eight quarters.
- Across the past five years, year-over-year decline in Total Debt ran from 5.9% in Q4 2023 to 23.9% in Q2 2026.
- Business Quant data shows GANX's Total Debt at $373,546 (Q1 2026), $400,953 (Q4 2025) and $424,342 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,135.43 Bn | 1,104.02 Bn | 19.71 Bn | 54.91 Bn |
| 2 | Johnson & Johnson | 616.54 Bn | 535.06 Bn | 17.26 Bn | 49.04 Bn |
| 3 | AbbVie | 501.55 Bn | 474.66 Bn | 12.70 Bn | 70.82 Bn |
| 4 | Merck | 367.19 Bn | 321.57 Bn | 12.21 Bn | 53.91 Bn |
| 5 | Novartis Ag | 297.91 Bn | 261.90 Bn | 11.24 Bn | 9.59 Bn |
| 6 | Astrazeneca | 261.40 Bn | 235.09 Bn | 12.86 Bn | 32.35 Bn |
| 7 | Amgen | 236.18 Bn | 191.58 Bn | 7.24 Bn | 57.30 Bn |
| 8 | Gilead Sciences | 190.55 Bn | 164.75 Bn | 6.22 Bn | 26.25 Bn |
| 9 | Pfizer | 169.40 Bn | 116.05 Bn | 10.94 Bn | 63.19 Bn |
| 10 | Gain Therapeutics | 52.10 Mn | -7.19 Mn | - | 343,686.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 343,686.00 |
| Mar 31, 2026 | 373,546.00 |
| Dec 31, 2025 | 400,953.00 |
| Sep 30, 2025 | 424,342.00 |
| Jun 30, 2025 | 451,467.00 |
| Mar 31, 2025 | 427,597.00 |
| Dec 31, 2024 | 438,504.00 |
| Sep 30, 2024 | 494,410.00 |
| Jun 30, 2024 | 486,403.00 |
| Mar 31, 2024 | 507,684.00 |
| Dec 31, 2023 | 567,850.00 |
| Sep 30, 2023 | 544,219.00 |
| Jun 30, 2023 | 578,274.00 |
| Mar 31, 2023 | 587,496.00 |
| Dec 31, 2022 | 603,393.00 |
| Sep 30, 2022 | 585,283.00 |
| Jun 30, 2022 | 626,010.00 |
| Mar 31, 2022 | 647,513.00 |
| Dec 31, 2021 | 694,294.00 |
| Sep 30, 2021 | 706,812.00 |
API Access
Gain Therapeutics Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=GANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "GANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=GANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();